| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/09/2011 | CN1839151B Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs |
| 02/09/2011 | CN1816563B Polypeptides having binding affinity for HER2 |
| 02/09/2011 | CN101970678A Biological active proteins having increased in vivo and/or vitro stability |
| 02/09/2011 | CN101970672A Use of rhizopus amylases in granular starch hydrolysis |
| 02/09/2011 | CN101970671A Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate |
| 02/09/2011 | CN101970666A Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 02/09/2011 | CN101970645A Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 02/09/2011 | CN101970498A Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 02/09/2011 | CN101970481A Demannosylated recombinant factor viii for the treatment of patients with hemophiila a |
| 02/09/2011 | CN101970480A Method |
| 02/09/2011 | CN101970479A Lxr ligand binding domain (lxr lbd) crystals |
| 02/09/2011 | CN101970478A Modulation of sirpalphalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 02/09/2011 | CN101970477A Protease-stabilized insulin analogues |
| 02/09/2011 | CN101970476A Novel insulin derivatives having an extremely delayed time-action profile |
| 02/09/2011 | CN101970475A Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour |
| 02/09/2011 | CN101970474A Cyclic, cystein-free protein |
| 02/09/2011 | CN101970473A Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 02/09/2011 | CN101970472A Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 02/09/2011 | CN101970471A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 02/09/2011 | CN101970470A Novel bacillus thuringiensis gene with coleopteran activity |
| 02/09/2011 | CN101970469A Production of heterologous proteins or peptides |
| 02/09/2011 | CN101970468A Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 02/09/2011 | CN101970467A Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
| 02/09/2011 | CN101970465A Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 02/09/2011 | CN101970464A Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 02/09/2011 | CN101970463A Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 02/09/2011 | CN101970052A Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 02/09/2011 | CN101970013A Novel therapeutical tools and methods for treating blindness |
| 02/09/2011 | CN101969998A A truncated form of the HIV p17 protein |
| 02/09/2011 | CN101969991A Malaria vaccine compositions and constituents which elicit cell mediated immunity |
| 02/09/2011 | CN101969962A Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins |
| 02/09/2011 | CN101968490A Indirect ELISA (Enzyme-Linked Immunosorbent Assay) method and kit for detecting haemophilus parasuis antibodies |
| 02/09/2011 | CN101968489A Enzyme linked immunoassay kit for detecting sheep coenuruses |
| 02/09/2011 | CN101967492A Simple and easy solubility expression and purifying method for recombinant human amyloid polypeptide A beta 42 |
| 02/09/2011 | CN101967487A Cystatin gene of monosomic addition line M14 of sugar beet |
| 02/09/2011 | CN101967486A Insect-resistant gene OsRGI and encoded product and application thereof |
| 02/09/2011 | CN101967485A Human FGF21 mutant gene and method for preparing recombinant human FGF21 protein |
| 02/09/2011 | CN101967467A Production and application of high-stability recombination carboxypeptidase B |
| 02/09/2011 | CN101967190A Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 of probnp |
| 02/09/2011 | CN101967188A Process for preparing human antihemophilic factor VIII |
| 02/09/2011 | CN101967187A Protein related to cell stress, and coding gene and application thereof |
| 02/09/2011 | CN101967186A Encephalitis virus protein and code gene and application thereof |
| 02/09/2011 | CN101967185A Encephalitis virus protein as well as coding gene and application thereof |
| 02/09/2011 | CN101967184A Prokaryotic expressed protein of coat protein gene of cymbidium mosaic virus, preparation method and application thereof |
| 02/09/2011 | CN101967128A Benzo uracil PNA (Peptide Nucleic Acid) monomer and intermediate thereof as well as preparation methods and applications of benzo uracil PNA and intermediate thereof |
| 02/09/2011 | CN101966337A Genetic products differentially expressed in tumors and the use thereof |
| 02/09/2011 | CN101352573B Recombinant human granulocyte colony stimulating factor lysine defect body modified by polyethyleneglycol |
| 02/09/2011 | CN101100484B Method for fast purifying cysteine protease inhibitor |
| 02/08/2011 | USRE42129 DNA based tests for the presence of the obesity associated virus adenovirus type 36; for reducing levels of triglycerides and cholesterol in humans |
| 02/08/2011 | US7884199 HCV NS3-NS4 protease resistance mutants |
| 02/08/2011 | US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 02/08/2011 | US7884194 epidermal growth factor receptors 2 and 3 proteins; antiproliferative; cancer |
| 02/08/2011 | US7884193 Antibodies for identification of murine fragilis extracellular domain and methods for identifying pluripotent cells |
| 02/08/2011 | US7884192 Twin-arginine translocation in Bacillus |
| 02/08/2011 | US7884191 Twin-arginine translocation in Bacillus |
| 02/08/2011 | US7884190 Recombinant dimeric and heterodimeric proteins comprising amino acids 193 to 252 of the β chain of the human C4BP protein |
| 02/08/2011 | US7884189 Carboxyltransferase domain of acetyl-CoA carboxylase |
| 02/08/2011 | US7884188 polypeptide obtained from a haematophagous arthropod that inhibits the classical complement pathway and the alternative complement pathway by inhibiting cleavage of C5 by classical and alternative C5 convertases |
| 02/08/2011 | US7884182 Chemical peptide ligation with three or more components |
| 02/08/2011 | US7884180 binds formyl peptide receptor-like 1 (FPRL1); useful for treating disorders associated with G-protein coupled receptor activation |
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7884178 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 02/08/2011 | US7884075 such as polyethylene glycol or polysialic acid; prolonging in vivo-half-life in blood |
| 02/08/2011 | US7884073 Modified growth hormone |
| 02/08/2011 | US7884071 Gels containing luteinizing hormone releasing hormone antagonist (ozarelix) in lyophilized form, aqueous solution of sodium chloride; colloids; for treating hormone related disorders, prostate cancer, breat cancer, uterine myomas, endometriosis, puberty disorders, and reproductive disorders |
| 02/08/2011 | US7884070 for treating Cryptococcus infection in humans, animals, and plants |
| 02/08/2011 | US7884069 Administering hematopoietic factor; Granulocyte-colony stimulating factor, granulocyte- macrophage CSF (GM-CSF), interleukin-3 (IL-3), and IL-5; neuralogical conditions, ischemia or hypoxia, depression |
| 02/08/2011 | US7884067 Peptides derived from cadherin and methods of use thereof |
| 02/08/2011 | US7884053 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation |
| 02/08/2011 | US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma |
| 02/08/2011 | US7883895 capable of modulating exopolysaccharide production in Sphingomonas; using such nucleic acid sequences to generate bacteria that hyper-produce exopolysaccharide in slime form; produce exopolysaccharide in a form that does not increase the viscosity of a fermentation broth |
| 02/08/2011 | US7883889 Using 5-aza-cytidine or 5-aza-2'-deoxycytidine to hypomethylate cells expressing tumor associated antigens; immunotherapy; genetic vaccines and the diagnosis, prevention and treatment of cancer |
| 02/08/2011 | US7883888 Replication incompetent Adenovirus (AdV) vectors, selectively killing cancer cells |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | US7883877 Compositions and methods for enhanced bacterial exopolysaccharide production |
| 02/08/2011 | US7883870 Nucleotide sequences coding bacterial transcription factor for use in detection and characterization of staphylococcal subspecies |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883866 Compositions of aminoacyl-tRNA synthetase and uses thereof |
| 02/08/2011 | US7883856 Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators |
| 02/08/2011 | US7883850 Cry1F and Cry1Ac transgenic cotton lines and event-specific identification thereof |
| 02/08/2011 | US7883846 Heterologous stimulus-gated ion channels and methods of using same |
| 02/08/2011 | US7883845 using Human immunodeficiency virus-1 group O/M envelope polypeptide fusion as evaluative tool in diagnosing viral infection |
| 02/08/2011 | US7883843 Using primate hepadnavirus loop region polypeptide sequences as tool in developing vaccine to prevent and treat viral infection |
| 02/08/2011 | US7883712 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti |
| 02/08/2011 | US7883710 Peptide vaccines against Group A streptococci |
| 02/08/2011 | US7883709 Stabilised compositions |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | US7883696 deliver transgenes of interest and suppressors of the eukaryotic Type I interferon response to eukaryotic cells; Suppression of the eukaryotic Type I interferon response allows improved expression of the encoded transgene |
| 02/08/2011 | US7883695 IL-12P40 and IL-B30 polypeptide complex |
| 02/08/2011 | CA2639651C Orally administered peptides to ameliorate atherosclerosis |
| 02/08/2011 | CA2529124C Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 02/08/2011 | CA2325774C Coniothyrium minitans .beta.-(1,3) exoglucanase gene cbeg1 |
| 02/08/2011 | CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 02/08/2011 | CA2314186C Adjuvanted vaccine comprising a cpg oligonucleotide and an antigen from streptococcus pneumoniae |
| 02/08/2011 | CA2296797C Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/08/2011 | CA2295971C Pseudomonas exotoxin a-like chimeric immunogens |
| 02/08/2011 | CA2295849C Trichoderma reesei swollenin protein and encoding dna sequence |
| 02/08/2011 | CA2285703C Detection of dna damaging agents |